As of April 19, 2025, Lexicon Pharmaceuticals (LXRX) has a market cap of $0.18 billion USD. According to our data, Lexicon Pharmaceuticals is ranked No.7063 in global market value.
Year | Market Cap | %Change |
---|---|---|
Apr 19, 2025 | $0.18 B |
-31.11%
|
Dec 31, 2024 | $0.27 B |
-51.63%
|
Dec 29, 2023 | $0.55 B |
-19.90%
|
Dec 30, 2022 | $0.69 B |
-51.52%
|
Dec 31, 2021 | $1.42 B |
15.20%
|
Dec 31, 2020 | $1.24 B |
-17.59%
|
Dec 31, 2019 | $1.50 B |
-37.50%
|
Dec 31, 2018 | $2.40 B |
-32.79%
|
Dec 29, 2017 | $3.57 B |
-28.56%
|
Dec 30, 2016 | $5.00 B |
3.91%
|
Dec 31, 2015 | $4.81 B |
108.95%
|
Dec 31, 2014 | $2.30 B |
-49.44%
|
Dec 31, 2013 | $4.55 B |
-18.55%
|
Dec 31, 2012 | $5.59 B |
71.32%
|
Dec 30, 2011 | $3.26 B |
-10.42%
|
Dec 31, 2010 | $3.64 B |
-15.29%
|
Dec 31, 2009 | $4.30 B |
21.43%
|
Dec 31, 2008 | $3.54 B |
-53.80%
|
Dec 31, 2007 | $7.67 B |
-16.07%
|
Dec 29, 2006 | $9.13 B |
-1.10%
|
Dec 30, 2005 | $9.24 B |
-52.96%
|
Dec 31, 2004 | $19.64 B |
31.75%
|
Dec 31, 2003 | $14.90 B |
24.52%
|
Dec 31, 2002 | $11.97 B |
-59.01%
|
Dec 31, 2001 | $29.20 B |
-30.59%
|
Dec 29, 2000 | $42.07 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
![]() Eli Lilly
LLY
|
$754.27 B |
0.008 M
|
![]() USA
|
![]() Novo Nordisk
NVO
|
$285.37 B |
89.978 B
|
![]() Denmark
|
![]() Sanofi
SNY
|
$124.64 B |
0.327 B
|
![]() France
|
![]() Pfizer
PFE
|
$125.57 B |
0.001 M
|
![]() USA
|
![]() Merck
MRK
|
$196.28 B |
0.008 M
|
![]() USA
|
![]() AstraZeneca
AZN
|
$210.29 B |
0.735 B
|
![]() UK
|
![]() GlaxoSmithKline
GSK
|
$72.79 B |
-0.000 M
|
![]() UK
|
![]() Bristol-Myers Squibb
BMY
|
$100.17 B |
-0.004 M
|
![]() USA
|
![]() Johnson & Johnson
JNJ
|
$379.48 B |
-0.003 M
|
![]() USA
|
![]() Amgen
AMGN
|
$149.09 B |
0.124 B
|
![]() USA
|
![]() Biogen
BIIB
|
$17.36 B |
-0.001 M
|
![]() USA
|
![]() Regeneron Pharmaceuticals
REGN
|
$61.57 B |
1.023 B
|
![]() USA
|
![]() Vertex Pharmaceuticals
VRTX
|
$125.74 B |
-0.003 M
|
![]() USA
|
![]() Gilead Sciences
GILD
|
$130.32 B |
-0.001 M
|
![]() USA
|
![]() Novartis
NVS
|
$219.89 B |
0.932 B
|
![]() Switzerland
|
Market Cap | = | LXRX Stock Price | * | LXRX Shares Outstanding |
= | $0.51 | * | 0.36 B | |
= | $0.18 B |